Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06003101 · ClinicalTrials.gov registry record · Phase 3
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
A Phase 3 study of Femoroacetabular Impingement and Chondral Defect, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06003101: Recruiting Phase 3 study of Femoroacetabular Impingement and Chondral Defect, sponsored by Massachusetts General Hospital.
NCT06003101 is a Phase 3 study of Femoroacetabular Impingement and Chondral Defect that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 160 participants, below the 1,350-participant average among 8 other Femoroacetabular Impingement trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06003101, a Phase 3 study of Femoroacetabular Impingement and Chondral Defect, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?
Primary Outcome
Patient Reported Outcome Measurement (PROM) to assess the patient's functional outcomes post-surgery. Range: 0-10, with 0 being no pain and 10 being the worst pain imaginable.
Conditions Studied
Interventions
- BIOLOGICAL Bone marrow aspirate concentrate (BMAC)
- PROCEDURE Control
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2045-08-30 |
| Phase | Phase 3 |
What NCT06003101 shows while recruiting
NCT06003101 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,350-participant average among 8 other Femoroacetabular Impingement trials with a reported enrollment target (88% lower).
The record links to 4 conditions, with Femoroacetabular Impingement appearing as the primary indexed condition, and to 2 interventions - of which Bone marrow aspirate concentrate (BMAC) is the first listed.
NCT06003101 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06003101 about?
NCT06003101 is a clinical study titled "Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies". The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to ...
What is the current status of trial NCT06003101?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2023-08-30. Estimated completion is 2045-08-30.
What conditions does trial NCT06003101 study?
This clinical trial studies the following conditions: Femoroacetabular Impingement, Chondral Defect, Acetabular Labrum Tear, Bone Marrow Aspirate Concentrate.
What interventions are being tested in trial NCT06003101?
The interventions under investigation include: Bone marrow aspirate concentrate (BMAC) (BIOLOGICAL), Control (PROCEDURE).
Who is sponsoring clinical trial NCT06003101?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06003101 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoroacetabular Impingement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06003101's enrollment target sits among peer trials
160 3rd of 8 higher than 6 of 8 other Femoroacetabular Impingement trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Femoroacetabular Impingement trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
An Evaluation of Hip Preservation Outcomes
RECRUITING
-
Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
RECRUITING · Phase 4
-
Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear
RECRUITING
-
SCP Hip Outcomes Study
ACTIVE NOT RECRUITING
-
Cam Decompression Utilizing the Stryker Hip-Check Software Platform
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI